We are live on !
Find out more
Jefferies Group Portfolio holdings
AUM
$12B
Turnover
50.93%
1-Year Est. Return
6.2%
This Fund
S&P 500
This Quarter Est. Return
+12.71%
1 Year Est. Return
-6.2%
3 Year Est. Return
+88.85%
5 Year Est. Return
+123.14%
10 Year Est. Return
–
AUM
$11.4B
AUM Growth
-$1.32B
(-10%)
Cap. Flow
-$1.04B
Cap. Flow % of AUM
Cap. Flow %
-9.13%
Top 10 Holdings %
Top 10 Hldgs %
33.33%
Holding
2,186
New
650
Increased
343
Reduced
428
Closed
611
Avg Time Held
Equity + Options
1
year
Top 10 Avg Time Held
Equity + Options
1.9
years
Top 20 Avg Time Held
Equity + Options
1.3
years
Avg Time Held Equity only
1
year
Top 10 Avg Time Held Equity only
0.1
years
Top 20 Avg Time Held Equity only
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$125M |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$62.1M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$60.4M |
| 4 |
Gaotu Techedu
GOTU
|
+$44.6M |
| 5 |
Vipshop
VIPS
|
+$32.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$156M |
| 2 |
Avis
CAR
|
+$140M |
| 3 |
Warner Bros
WBD
|
+$124M |
| 4 |
Danimer Scientific, Inc.
DNMR
|
+$90.2M |
| 5 |
Star Bulk Carriers
SBLK
|
+$73.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 77.05% |
| 2 | Healthcare | 4.05% |
| 3 | Technology | 3.86% |
| 4 | Consumer Discretionary | 2.79% |
| 5 | Financials | 2.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$800B
| $965M | 8.46% |
2,435,608
+152,508
| +7% | +$58.8M |
2013 Q2
31 quarters
|
|
2
PUT
Invesco QQQ Trust
QQQ
$467B
| $760M | 6.66% |
2,380,082
+1,328,582
| +126% | +$425M |
2013 Q4
29 quarters
|
|
|
3
PUT
iShares Russell 2000 ETF
IWM
$76.4B
| $471M | 4.12% |
2,129,800
+114,200
| +6% | +$24.9M |
2013 Q2
31 quarters
|
|
|
4
State Street SPDR S&P 500 ETF Trust
SPY
$800B
| $396M | 3.47% |
998,094
-404,597
| -29% | -$156M |
2013 Q2
31 quarters
|
|
|
5
PUT
iShares MSCI Emerging Markets ETF
EEM
$28.2B
| $300M | 2.63% |
5,625,900
+1,835,700
| +48% | +$101M |
2013 Q2
31 quarters
|
|
6
PUT
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.9B
| $223M | 1.95% |
1,711,300
+1,709,300
| +85,465% | +$227M |
2019 Q3
6 quarters
|
|
|
7
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$800B
| $201M | 1.76% |
507,100
-270,100
| -35% | -$104M |
2013 Q2
31 quarters
|
|
|
8
CALL
Invesco QQQ Trust
QQQ
$467B
| $176M | 1.54% |
551,000
-86,200
| -14% | -$27.6M |
2017 Q1
16 quarters
|
|
|
9
iShares MSCI Emerging Markets ETF
EEM
$28.2B
| $156M | 1.37% |
2,927,552
+2,282,475
| +354% | +$125M |
2013 Q2
31 quarters
|
|
|
10
iShares Russell 2000 ETF
IWM
$76.4B
| $156M | 1.37% |
706,692
+276,854
| +64% | +$60.4M |
2013 Q2
31 quarters
|
|
11
PUT
Alibaba
BABA
$235B
| $133M | 1.17% |
588,700
-528,600
| -47% | -$130M |
2014 Q4
25 quarters
|
|
12
CALL
State Street Financial Select Sector SPDR ETF
XLF
$54.3B
| $127M | 1.11% |
3,729,100
+2,937,100
| +371% | +$94.3M |
2019 Q3
6 quarters
|
|
13
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$18.1B
| $117M | 1.03% |
1,342,700
+360,200
| +37% | +$31.3M |
2014 Q3
26 quarters
|
|
|
14
CALL
iShares Russell 2000 ETF
IWM
$76.4B
| $109M | 0.96% |
493,800
-182,600
| -27% | -$39.9M |
2013 Q2
31 quarters
|
|
15
CALL
State Street Energy Select Sector SPDR ETF
XLE
$42.6B
| $89M | 0.78% |
3,630,000
+2,902,000
| +399% | +$66.9M |
2014 Q4
25 quarters
|
|
16
CALL
SPDR Gold Trust
GLD
$130B
| $86.8M | 0.76% |
542,500
+2,500
| +0.5% | +$420K |
2020 Q4
1 quarter
|
|
17
CALL
Snap
SNAP
$9.08B
| $80.6M | 0.71% |
1,541,500
-995,000
| -39% | -$57.2M |
2020 Q3
2 quarters
|
|
|
18
PUT
Snap
SNAP
$9.08B
| $77.3M | 0.68% |
1,478,179
+323,179
| +28% | +$18.6M |
2019 Q2
7 quarters
|
|
|
19
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.2B
| $75.1M | 0.66% |
553,600
-271,600
| -33% | -$40.7M |
2015 Q3
22 quarters
|
|
|
20
CALL
iShares MSCI Emerging Markets ETF
EEM
$28.2B
| $72M | 0.63% |
1,350,600
-11,996,000
| -90% | -$657M |
2013 Q2
31 quarters
|
|
21
CALL
DELISTED
Splunk Inc
SPLK
| $72M | 0.63% |
531,100
+387,300
| +269% | +$60.4M |
2019 Q1
8 quarters
|
|
22
CALL
Chevron
CVX
$429B
| $69.9M | 0.61% |
+666,600
| New | +$65.1M |
2021 Q1
0 quarters
|
|
23
PUT
ARK Innovation ETF
ARKK
$5.95B
| $68.5M | 0.6% |
+571,300
| New | +$77.3M |
2021 Q1
0 quarters
|
|
|
24
State Street SPDR S&P Biotech ETF
XBI
$10.2B
| $64.4M | 0.56% |
474,500
+414,500
| +691% | +$62.1M |
2015 Q2
23 quarters
|
|
25
PUT
Biogen
BIIB
$37.5B
| $60M | 0.53% |
214,600
+197,600
| +1,162% | +$53.3M |
2015 Q2
23 quarters
|
|
Similar funds
APA
Jefferies Group's Q1 2021 Portfolio in Review
As of Q1 2021, Jefferies Group held 2,186 positions worth $11.4B, down 10% from $12.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Jefferies Group withdrew a net $1.04B in Q1 2021, closing 611 positions and reducing 428 holdings. Its most notable exit was Texas Capital Bancshares, Inc. Common Stock, par value $0.01 per share, an estimated $40.8M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 77% of assets, up from 74% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Jefferies Group opened a new position in Futu Holdings worth $39.4M.
- Jefferies Group's largest Q1 2021 buy was Futu Holdings: 248,100 shares worth $39.4M.
- Jefferies Group added most to iShares MSCI Emerging Markets ETF in Q1 2021, an estimated $125M increase.
- Jefferies Group's biggest Q1 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $156M.
- Jefferies Group fully exited Texas Capital Bancshares, Inc. Common Stock, par value $0.01 per share in Q1 2021, selling an estimated $40.8M.
- Jefferies Group's ten largest holdings make up 33% of its $11.4B portfolio in Q1 2021.
- Jefferies Group opened 650 new positions and closed 611 in Q1 2021.
- Jefferies Group's portfolio value fell 10% quarter-over-quarter to $11.4B.
Based on Jefferies Group's 13F filing for Q1 2021, filed 14 May 2021.